Trendspotter: In-Depth Analysis of Key Companies in Retail Research

Broker Name: CGS International Securities

Date of Report: December 4, 2024

Yoma Strategic Holdings Ltd – A Bullish Continuation?

Yoma Strategic Holdings Ltd., operating as a holding company, through its subsidiaries, develops, constructs, and sells private and residential real estate properties across Asia. The company’s technical analysis suggests a possible strong bullish reversal, indicating a promising uptrend.

Key pointers for Yoma Strategic include:

• Breaking out of a larger falling wedge formation, indicating early confirmation of reversal.
• Rebound and closure above the 78.6% Fibonacci key deep retracement level of S\$0.068, from S\$0.039-S\$0.175 swing low to high.
• Bullish closure above the 9-period conversion and 26-period base line, signaling an early sign of bullish reversal.
• Stochastic Oscillator forming an oversold crossover.
• 23-period ROC rising above the zero line, forming a bullish divergence.
• Directional movement index indicating strong bullish strength.
• Volume spike above the 20-period average, indicating sustained bullish strength.

The entry prices are set at 0.082, 0.070, and 0.062, with support levels at 0.068 and 0.060. The stop loss is marked at 0.054. Resistance levels are identified at 0.117 and 0.175, with target prices extending to 0.117, 0.173, 0.230, and 0.300.

Simcere Pharmaceutical Group Ltd – Technical Buy

Simcere Pharmaceutical Group Ltd., listed on the Hong Kong Stock Exchange under (2096), is identified as a technical buy. The company is involved in the pharmaceutical sector, and the recommendation comes amidst expectations of a bullish outlook.

The entry prices are strategically set at 7.30, 6.80, and 6.30. A stop loss is placed at 5.87, with ambitious targets reaching 8.85, 10.10, 13.22, and 15.00.

Perfect Medical – Consumption Recovery Expected

Perfect Medical, another Hong Kong-listed company, anticipates a consumption recovery in the second half of FY25F. Despite a 15% year-on-year fall in core net profit in the first half of FY3/25, primarily due to weak consumption in Hong Kong and China, a positive outlook is maintained.

The revenue in China is expected to fall approximately 10% year-on-year in FY25F, attributed to fewer new store openings and no price adjustments. Despite this, an “Add” recommendation is reiterated with a revised target price of HK\$3.40, based on a 10x CY26F P/E.

L.K. Technology Holdings Ltd – Anticipating Sequential Recovery

L.K. Technology Holdings Ltd. is another Hong Kong-listed entity expected to experience a sequential recovery in 2HFY3/25FF. While the report does not provide exhaustive details, it suggests a positive future outlook for the company.

MIDI Utama Indonesia – An Underrated Alpha

MIDI Utama Indonesia is highlighted as an underrated alpha in its group. While specific details are limited, the mention suggests a potential opportunity for investors looking for hidden gems.

Bank Mandiri – Insights from BMRI Group Call

Bank Mandiri, a notable financial institution in Indonesia, offers key takeaways from its BMRI group call. The insights presumably provide valuable information for stakeholders and investors interested in the bank’s strategic direction.

This comprehensive analysis, provided by CGS International Securities, offers valuable insights into several key companies, highlighting potential investment opportunities and market trends as of December 4, 2024.